Abstract:OBJECTIVE:To evaluate the correlation of CD44v6 and sCD44v6 expression with the biological activity of gastric carcinoma. METHODS:Mucosa samples from 103 gastric carcinoma patients and 10 healthy persons (control) were examined using immunohistochemical SP method; sCD44v6 level in peripheral blood samples was detected with ELISA in 86 gastric cancer patients, 30 gastric ulcer patients and 30 healthy controls. The follow-up period was 3-91 months for 88 patients in CD44v6 group and 1-91 months for 55 patients in sCD44v6 group. RESULTS:(1) Positive expression of CD44v6 was found in 60.2% of gastric carcinoma, where as 0% in the normal gastric mucosa. CD44v6 protein expression was positively correlated with TNM stage, perigastric lymph node metastasis, presence of cancerous embolic angiopathy and Borrmann classification (P <0.05), but was not correlated with invasion depth, differentiation, metastasis and survival (P > 0.05); 77.8% of the patient with liver metastasis had a strong CD44v6 protein expression. (2) sCD44v6 level in the peripheral blood of gastric carcinoma patient was significantly higher than that in gastric ulcer patient or healthy control; Compared with palliative gastrectomy, sCD44v6 level significantly went down after radical operation. No relationship between sCD44v6 level and the pathological features was found, which included invasion depth, perigastric lymph node metastasis, presence of cancerous embolic angiopathy, differentiation and Borrmann classification; The survival in the high sCD44v6 level group was longer than that in low sCD44v6 level group ( P = 0.0281), but no significant difference was observed by Cox Regression analysis (P = 0.415). (3) No apparent correlation was observed between CD44v6 expression in gastric cancer and sCD44v6 concentration in peripheral blood (P>0.05). CONCLUSION:Detection of CD44v6 expression in the gastric cancer may be helpful in evaluating the biological features and the survival in gastric carcinoma. The level of sCD44v6 in the blood may be also helpful in differential diagnosis, evaluation of surgical treatment and biological activity for gastric cancer. No apparent correlation is observed between CD44v6 expression in the cancer and that of sCD44v6 in the blood.

Expressions of ABCG2 and CD44~+/CD24~- cells in breast carcinoma and their relationship with prognosis

[Pilot Study on the Correlation Between High Incidence of CD44+/CD24 -/Low/abcg2- Cells and Poor Prognosis in Breast Cancer].

[Expression and Clinical Significance of CD44v6 and Scd44v6 in Gastric Carcinoma].

[Study on the Correlation Factors on CD44+ CD24-/low ESA+ Lin- Cell Ratio in Breast Cancer].

The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas

The Clinical Significance of the CD44v6 Expression in Peripheral Blood Mononuclear Cell and Cancerous Tissue of Patients with Gastric Cancer

[Quantitative Studies on Expression of Peripheral Blood CD44 and CD54 in Non-Small Cell Lung Carcinoma].

Expressions of Progesterone Receptor a and B in Breast Invasive Ductal Carcinoma and Their Clinical Significance

CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma

CD44s expression study in colorectal cancer tissues

[Relationship Between the Protein Expression of P53, C-Erbb-2, Vascular Endothelial Growth Factor and CD44 and the Survival Rates of Stage II( Colorectal Cancer Patients Without Radiochemotherapy after Radical Resection].

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas

Expression of C-erbB-2 and nm23 proteins in breast cancer and their clinical signifi cance

Detection of CD44+CD24-/low in breast cancer stem cells and clinical significance

Expression of ATP-binding Cassette Superfamily G Member 2 and Β-Tubulin-ⅲ in Human Breast Carcinomas and Clinical Significance

[Expression of CK5/6 and CK17 and Its Correlation with Prognosis of Triple-Negative Breast Cancer Patients].

Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma

CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer.

Expression and Significance of ABCG2 in Transitional Cell Carcinoma of Bladder

Research on the Correlation among Expression Rates of CD44s,CD44V5 and CD44V6 in Peripheral Blood Cells of Patients with Colorectal Carcinoma

[Expression of ATP-binding Cassette Transporter ABCG2 in Gastric Carcinoma and Its Significance].